Details

Autor(en) / Beteiligte

• Farinacci, Damiano
• Iannone, Valentina
• D'Angelillo, Anna
• Borghetti, Alberto
• Passerotto, Rosa Anna
• Lamanna, Francesco
• Di Giambenedetto, Simona

Titel

Two-Drug Regimen Containing Darunavir: Metabolic Evaluation of an Old Dual Therapy

Ist Teil von

• AIDS research and human retroviruses, 2023-12, Vol.39 (12), p.633-635

Ort / Verlag

United States

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Regimens containing darunavir are one of the first one with two drugs that demonstrated good efficacy as a simplification strategy. We wanted to describe the characteristics of patients followed in our center on a dual therapy regimen containing darunavir evaluating the metabolic aspects during follow-ups. We collected data from 208 patients switching to lamivudine plus darunavir with either ritonavir or cobicistat between 2010 and 2019. In all patients we found an increase in low-density lipoprotein (LDL), with no rising in creatinine, total cholesterol, or triglycerides. Twenty-five patients reached 120 weeks of follow-up. In these patients, no significant metabolic changes were described without concomitant treatment with drugs for dyslipidemia. These regimens seem to be more tolerable in metabolic profile compared with the data concerning three-drug therapies, leading only to a slight increase in LDL. The main reason for discontinuation was for a single-tablet therapy. None of the patients started treatment for dyslipidemia.